Literature DB >> 21686075

The Role of Genetics in Nicotine Dependence: Mapping the Pathways from Genome to Syndrome.

James Mackillop1, Ezemenari Obasi, Michael T Amlung, John E McGeary, Valerie S Knopik.   

Abstract

Nicotine dependence continues to be a major public health problem worldwide and there is unequivocal evidence that genetics play a substantial role in its etiology. This review provides an overview of the evidence for genetic influences and recent advances in the field. Traditional quantitative genetics studies have revealed nicotine dependence is heritable and molecular genetics studies are providing increasing evidence that the genes responsible for nicotine's pharmacokinetics and pharmacodynamics are particularly important. Despite considerable progress, a number of significant complexities and challenges remain. These include determining the specificity of genetic influences and clarifying the role of interactive contributions. One promising strategy for addressing these issues is an intermediate phenotype approach that attempts to identify the intervening proximal mechanisms that confer differential genetic risk. Understanding these mechanisms may permit more precision in understanding genetic influences and may also identify novel targets for intervention or prevention.

Entities:  

Year:  2010        PMID: 21686075      PMCID: PMC3114454          DOI: 10.1007/s12170-010-0132-6

Source DB:  PubMed          Journal:  Curr Cardiovasc Risk Rep        ISSN: 1932-9520


  48 in total

Review 1.  Population stratification in the candidate gene study: fatal threat or red herring?

Authors:  Kent E Hutchison; Michael Stallings; John McGeary; Angela Bryan
Journal:  Psychol Bull       Date:  2004-01       Impact factor: 17.737

2.  Significant association of catechol-O-methyltransferase (COMT) haplotypes with nicotine dependence in male and female smokers of two ethnic populations.

Authors:  Joke Beuten; Thomas J Payne; Jennie Z Ma; Ming D Li
Journal:  Neuropsychopharmacology       Date:  2006-03       Impact factor: 7.853

3.  Exploring the inter-relationship of smoking age-at-onset, cigarette consumption and smoking persistence: genes or environment?

Authors:  Katherine I Morley; Michael T Lynskey; Pamela A F Madden; Susan A Treloar; Andrew C Heath; Nicholas G Martin
Journal:  Psychol Med       Date:  2007-04-30       Impact factor: 7.723

Review 4.  Genetic variation in the dopamine pathway and smoking cessation.

Authors:  Sean P David; Marcus R Munafò
Journal:  Pharmacogenomics       Date:  2008-09       Impact factor: 2.533

5.  CHRNA4 and tobacco dependence: from gene regulation to treatment outcome.

Authors:  Kent E Hutchison; David L Allen; Francesca M Filbey; Christopher Jepson; Caryn Lerman; Neal L Benowitz; Jerry Stitzel; Angela Bryan; John McGeary; Heather M Haughey
Journal:  Arch Gen Psychiatry       Date:  2007-09

6.  Specificity of genetic and environmental risk factors for symptoms of cannabis, cocaine, alcohol, caffeine, and nicotine dependence.

Authors:  Kenneth S Kendler; John Myers; Carol A Prescott
Journal:  Arch Gen Psychiatry       Date:  2007-11

Review 7.  Molecular genetics of nicotine metabolism.

Authors:  Jill C Mwenifumbo; Rachel F Tyndale
Journal:  Handb Exp Pharmacol       Date:  2009

8.  Multiple independent loci at chromosome 15q25.1 affect smoking quantity: a meta-analysis and comparison with lung cancer and COPD.

Authors:  Nancy L Saccone; Robert C Culverhouse; Tae-Hwi Schwantes-An; Dale S Cannon; Xiangning Chen; Sven Cichon; Ina Giegling; Shizhong Han; Younghun Han; Kaisu Keskitalo-Vuokko; Xiangyang Kong; Maria Teresa Landi; Jennie Z Ma; Susan E Short; Sarah H Stephens; Victoria L Stevens; Lingwei Sun; Yufei Wang; Angela S Wenzlaff; Steven H Aggen; Naomi Breslau; Peter Broderick; Nilanjan Chatterjee; Jingchun Chen; Andrew C Heath; Markku Heliövaara; Nicole R Hoft; David J Hunter; Majken K Jensen; Nicholas G Martin; Grant W Montgomery; Tianhua Niu; Thomas J Payne; Leena Peltonen; Michele L Pergadia; John P Rice; Richard Sherva; Margaret R Spitz; Juzhong Sun; Jen C Wang; Robert B Weiss; William Wheeler; Stephanie H Witt; Bao-Zhu Yang; Neil E Caporaso; Marissa A Ehringer; Tim Eisen; Susan M Gapstur; Joel Gelernter; Richard Houlston; Jaakko Kaprio; Kenneth S Kendler; Peter Kraft; Mark F Leppert; Ming D Li; Pamela A F Madden; Markus M Nöthen; Sreekumar Pillai; Marcella Rietschel; Dan Rujescu; Ann Schwartz; Christopher I Amos; Laura J Bierut
Journal:  PLoS Genet       Date:  2010-08-05       Impact factor: 5.917

9.  Significant association of ANKK1 and detection of a functional polymorphism with nicotine dependence in an African-American sample.

Authors:  Weihua Huang; Thomas J Payne; Jennie Z Ma; Joke Beuten; Randolph T Dupont; Naohiro Inohara; Ming D Li
Journal:  Neuropsychopharmacology       Date:  2008-03-19       Impact factor: 7.853

10.  Dopamine and opioid gene variants are associated with increased smoking reward and reinforcement owing to negative mood.

Authors:  Kenneth A Perkins; Caryn Lerman; Amy Grottenthaler; Melinda M Ciccocioppo; Melissa Milanak; Cynthia A Conklin; Andrew W Bergen; Neal L Benowitz
Journal:  Behav Pharmacol       Date:  2008-09       Impact factor: 2.293

View more
  8 in total

Review 1.  The behavioral economics of substance use disorders: reinforcement pathologies and their repair.

Authors:  Warren K Bickel; Matthew W Johnson; Mikhail N Koffarnus; James MacKillop; James G Murphy
Journal:  Annu Rev Clin Psychol       Date:  2014       Impact factor: 18.561

2.  NCAM1-TTC12-ANKK1-DRD2 variants and smoking motives as intermediate phenotypes for nicotine dependence.

Authors:  L C Bidwell; J E McGeary; J C Gray; R H C Palmer; V S Knopik; J MacKillop
Journal:  Psychopharmacology (Berl)       Date:  2014-10-03       Impact factor: 4.530

3.  Polygenic risk scores for cigarettes smoked per day do not generalize to a Native American population.

Authors:  Jacqueline M Otto; Ian R Gizer; Chris Bizon; Kirk C Wilhelmsen; Cindy L Ehlers
Journal:  Drug Alcohol Depend       Date:  2016-08-10       Impact factor: 4.492

4.  An initial investigation of associations between dopamine-linked genetic variation and smoking motives in African Americans.

Authors:  L C Bidwell; J E McGeary; J C Gray; R H C Palmer; V S Knopik; J MacKillop
Journal:  Pharmacol Biochem Behav       Date:  2015-09-26       Impact factor: 3.533

5.  Multi-Polygenic Analysis of Nicotine Dependence in Individuals of European Ancestry.

Authors:  Victoria A Risner; Chelsie E Benca-Bachman; Lauren Bertin; Alicia K Smith; Jaakko Kaprio; John E McGeary; Elissa Chesler; Valerie S Knopik; Naomi P Friedman; Rohan H C Palmer
Journal:  Nicotine Tob Res       Date:  2021-11-05       Impact factor: 4.244

6.  Effects of Evaluative Context in Implicit Cognitions Associated with Alcohol and Violent Behaviors.

Authors:  Ezemenari M Obasi; Lucia Cavanagh; Delishia M Pittman; Jessica J Brooks
Journal:  Addict Behav Rep       Date:  2016-06

7.  Targeted sequencing identifies genetic polymorphisms of flavin-containing monooxygenase genes contributing to susceptibility of nicotine dependence in European American and African American.

Authors:  Tian-Xiao Zhang; Nancy L Saccone; Laura J Bierut; John P Rice
Journal:  Brain Behav       Date:  2017-03-15       Impact factor: 2.708

Review 8.  Multifactorial Etiology of Adolescent Nicotine Addiction: A Review of the Neurobiology of Nicotine Addiction and Its Implications for Smoking Cessation Pharmacotherapy.

Authors:  Supriya D Mahajan; Gregory G Homish; Amanda Quisenberry
Journal:  Front Public Health       Date:  2021-07-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.